Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06258018
Title Niraparib and Temozolomide in Patients Glioblastoma (ONC-2022-001)
Acronym ONC-2022-001
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Armando Santoro, MD
Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST